Healthcare / Medical DistributionKuwait
$588.00
+9.00 (+1.55%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 26% · confianza 25%
FCF escenarios
weak_data · normalized FCF $22.9M · quality 40.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
20/100
D
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$104M
P/E
N/A
•EV/EBITDA
51228.0x
↑ROE
-30.6%
↓Gross Margin
19.3%
↓Debt/Equity
3.99
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-1.0%
FCF CAGR
-14.8%
FCF margin
14.3%
FCF / Net income
-1.41x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $160.4M · net income $-16.2M · FCF $22.9M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $160.4M | $160.4M | $179.2M | $168.6M | $165.5M |
| Net Income | $-16.2M | $-16.2M | $703897.00 | $5.0M | $7.0M |
| EBITDA | $2.1M | $2.1M | $20.5M | $23.8M | $22.0M |
| EPS | -0.09 | -0.09 | 0.00 | 0.03 | 0.04 |
| Gross Margin | 19.3% | 19.3% | 25.0% | 24.5% | 26.0% |
| Operating Margin | -6.8% | -6.8% | 5.7% | 7.8% | 8.5% |
| Net Margin | -10.1% | -10.1% | 0.4% | 3.0% | 4.2% |
| Balance Sheet | |||||
| Debt/Equity | 3.99 | 3.99 | 3.07 | 2.79 | 2.50 |
| Current Ratio | 1.17 | 1.17 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $22.9M | $22.9M | $851681.00 | $28.0M | $37.0M |
| Returns | |||||
| ROE | -30.6% | -30.6% | 1.0% | 7.0% | 10.1% |
| Valuation | |||||
| P/E | — | — | 82906.90 | 13569.75 | 9411.83 |
| EV/EBITDA | 51227.95 | 51227.95 | 2860.81 | 2873.36 | 3007.05 |
| P/B | 1987.26 | 1987.26 | 828.32 | 951.02 | 950.49 |
| Growth & Yield | |||||
| Revenue Growth | -10.5% | -10.5% | 6.3% | 1.9% | — |
| EPS Growth | -2415.9% | -2415.9% | -86.0% | -28.3% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-12.9%
Start / end P/E
n/dx → n/dx
EPS bridge
0.00 → -0.09
Residual
-12.9%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.